Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Registrati

Quotazioni in diretta

STIM Neuronetics Inc

1,46

0,13 (9,77%)

24 Dic 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

Date of Notice

10/08/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Stephen Furlong

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Neuronetics (NASDAQ:STIM)
Storico
Da Nov 2024 a Dic 2024

Clicca qui per i Grafici di Neuronetics

Grafico Azioni Neuronetics (NASDAQ:STIM)
Storico
Da Dic 2023 a Dic 2024

Clicca qui per i Grafici di Neuronetics

Notizie Neuronetics Inc - STIM

Form 3 - Initial statement of beneficial ownership of securities
Giovedì 19 Dicembre 2024 (5 giorni fa) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Giovedì 19 Dicembre 2024 (5 giorni fa) • Edgar (US Regulatory)

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mercoledì 18 Dicembre 2024 (6 giorni fa) • GlobeNewswire Inc.

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Mercoledì 18 Dicembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Lunedì 16 Dicembre 2024 (1 settimana fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 12 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 12 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 12 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Martedì 10 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Neuronetics and Greenbrook TMS Announce Closing of Transaction
Martedì 10 Dicembre 2024 (2 settimane fa) • GlobeNewswire Inc.

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
Mercoledì 20 Novembre 2024 (1 mese fa) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Giovedì 14 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Più Neuronetics Inc Articoli Notizie

Intesa Sanpaolo

Banca Monte Dei Paschi D...

ST Microelectronics

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea